BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 38435497)

  • 1. Undernutrition and associated factors among adults human immunodeficiency virus positive on antiretroviral therapy in hospitals, East Hararge Zone, Oromia, Ethiopia: A cross-sectional study.
    Dedha M; Damena M; Egata G; Negesa L
    Int J Health Sci (Qassim); 2017; 11(5):35-42. PubMed ID: 29114193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and psychosocial factors of quality of life among adult people living with HIV on Highly Active Antiretroviral Therapy, in public hospitals of Southwest Ethiopia.
    Gesese AA; Desta YG; Behire EZ
    PLOS Glob Public Health; 2022; 2(8):e0000822. PubMed ID: 36962396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Loss to Follow Up Among Adult People Living with HIV Enrolled in Antiretroviral Therapy in West Wollega Public Hospitals, Oromia, Ethiopia.
    Benti Biratu S; Addis Gesese A
    HIV AIDS (Auckl); 2024; 16():59-71. PubMed ID: 38435497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study.
    Zenu S; Tesema T; Reshad M; Abebe E
    PLoS One; 2021; 16(10):e0258930. PubMed ID: 34679085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of virologic failure among adult HIV patients on first line antiretroviral treatment in Oromia, Central Ethiopia: 2022 a case-control study.
    Ayana WG; Ayana Hordofa M; Dechasa Yadeta A
    AIDS Res Ther; 2024 Jun; 21(1):42. PubMed ID: 38915090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia.
    Megerso A; Garoma S; Eticha T; Workineh T; Daba S; Tarekegn M; Habtamu Z
    HIV AIDS (Auckl); 2016; 8():83-92. PubMed ID: 27175095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of HIV infection among children born to HIV positive mothers on prevention of mother to child transmission program at referral hospitals in west Amhara, Ethiopia; case control study.
    Alemu A; Molla W; Yinges K; Mihret MS
    Ital J Pediatr; 2022 Feb; 48(1):17. PubMed ID: 35115031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017.
    Belew H; Wubie M; Tizazu G; Bitew A; Birlew T
    BMC Infect Dis; 2020 Aug; 20(1):593. PubMed ID: 32787798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Loss to Follow-Up among HIV-Infected Adults after Initiation of the First-Line Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia: A 5-Year Retrospective Cohort Study.
    Gebremichael MA; Gurara MK; Weldehawaryat HN; Mengesha MM; Berbada DA
    Biomed Res Int; 2021; 2021():8659372. PubMed ID: 34805406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of lost to follow up from antiretroviral therapy among adults in sub-Saharan Africa: a systematic review and meta-analysis.
    Kebede HK; Mwanri L; Ward P; Gesesew HA
    Infect Dis Poverty; 2021 Mar; 10(1):33. PubMed ID: 33743815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of loss to follow-up among HIV-positive adults in northwest Ethiopia: a retrospective cohort study.
    Birhanu MY; Leshargie CT; Alebel A; Wagnew F; Siferih M; Gebre T; Kibret GD
    Trop Med Health; 2020; 48():78. PubMed ID: 32943978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.